TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2010

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.

Richard E Royal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.